Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pacira Pharmaceuticals ( (PCRX) ) has provided an announcement.
Pacira BioSciences, Inc. is set for a leadership transition as Charles A. Reinhart III, the CFO, plans to leave by September 30, 2024, staying on as a consultant for nine more months. Lauren Riker, the company’s Senior VP of Finance, will step up as the interim CFO from October 1. With a decade at Pacira and no direct or familial ties influencing her appointment, Riker will maintain her current salary and bonus structure, adding a $75,000 bonus for her new role, which comes with specific repayable conditions. Her employment terms include various severance and insurance benefits, with additional provisions in the event of a company “change of control.”
See more data about PCRX stock on TipRanks’ Stock Analysis page.